MedTrace Logo

An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)

NCT04524624 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21689

Last updated 2020-08-24

No results posted yet for this study

Summary

This study will conduct a cluster randomized controlled trial to evaluate the impact of an artificial intelligence-based clinical decision support system for the integrated management of patients with acute ischemic stroke on the adherence to guideline-based therapies and the incidence of new clinical vascular events.

Conditions

Interventions

DEVICE

AI-based CDSS

1. Automatically identifying acute ischemic stroke lesions on DWI. 2. Classification of stroke subtypes and mechanisms. 3. Evidence-based alerts and guidelines for early stroke management. 4. Guideline-recommended secondary stroke prevention strategies.

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    lead OTHER

Principal Investigators

  • Yongjun Wang, MD · Beijing Tian Tan Hospital, Capital Medical University, Beijing, China

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2022-09-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04524624 on ClinicalTrials.gov